Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management.
autonomous dysfunction
cardiovascular
dysautonomia
post-COVID-19 condition
pulmonary
Journal
Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
medline:
23
10
2023
pubmed:
15
5
2023
entrez:
14
5
2023
Statut:
ppublish
Résumé
A significant proportion of COVID-19 patients experience debilitating symptoms for months after the acute infection. According to recent estimates, approximately 1 out of 10 COVID-19 convalescents reports persistent health issues more than 3 months after initial recovery. This 'post-COVID-19 condition' may include a large variety of symptoms from almost all domains and organs, and for some patients it may mean prolonged sick-leave, homestay and strongly limited activities of daily life. In this narrative review, we focus on the symptoms and signs of post-COVID-19 condition in adults - particularly those associated with cardiovascular and respiratory systems, such as postural orthostatic tachycardia syndrome or airway disorders - and explore the evidence for chronic autonomic dysfunction as a potential underlying mechanism. The most plausible hypotheses regarding cellular and molecular mechanisms behind the wide spectrum of observed symptoms - such as lingering viruses, persistent inflammation, impairment in oxygen sensing systems and circulating antibodies directed to blood pressure regulatory components - are discussed. In addition, an overview of currently available pharmacological and non-pharmacological treatment options is presented.
Substances chimiques
Antibodies
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
548-562Informations de copyright
© 2023 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
Références
World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Accessed 17 May, 2023. https://covid19.who.int/2023
Crook H, Raza S, Nowell J, Young M, Edison P. Long Covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.
Hedberg P, Granath F, Bruchfeld J, Askling J, Sjöholm D, Fored M, et al. Post COVID-19 condition diagnosis: a population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. J Intern Med. 2023;293(2):246-58.
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, Mcgroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-15.
Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-7.
Huang L, Li X, Gu X, Zhang H, Ren L, Guo Li, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863-76.
Ballering AV, Van Zon SKR, Olde Hartman TC, Rosmalen JGM. Lifelines Corona Research I. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452-61.
Greenhalgh T, Knight M, A'court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026.
Wahlgren C, Forsberg G, Divanoglou A, Östholm Balkhed Å, Niward K, Berg S, et al. Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. Lancet Reg Health Eur. 2023:100595.
Brodin P. SARS-CoV-2 infections in children: understanding diverse outcomes. Immunity. 2022;55(2):201-9.
Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20(10):1115-7.
Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9(10):815-27.
Brodin P, Casari G, Townsend L, O'farrelly C, Tancevski I, Löffler-Ragg J, et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022;28(5):879-82.
Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P, et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul Pharmacol. 2022;144:106975.
Johansson M, Ståhlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, et al. Long-Haul Post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021;3(4):573-80.
Ståhlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Yu, Bax J, et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021;134(12):1451-6.
Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157-72.
Bisaccia G, Ricci F, Recce V, Serio A, Iannetti G, Chahal AA, et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J Cardiovasc Dev Dis. 2021;8(11):156.
Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long COVID - an update for primary care. BMJ. 2022;378:e072117.
Meringer H, Mehandru S. Gastrointestinal post-acute COVID-19 syndrome. Nat Rev Gastroenterol Hepatol. 2022;19(6):345-6.
Feigofsky S, Fedorowski A. Defining cardiac dysautonomia - different types, overlap syndromes; case-based presentations. J Atr Fibrillation. 2020;13(1):2403.
Goldstein DS. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med. 2002;137(9):753-63.
Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. 2019;285(4):352-66.
Biaggoni IBK, Fink G, Jordan J, Low PA, Paton JFR. Primer on the autonomic nervous system. 4th ed. Amsterdam, the Netherlands: Elsevier Academic Press; 2022.
Schwendinger F, Knaier R, Radtke T, Schmidt-Trucksass A. Low cardiorespiratory fitness post-COVID-19: a narrative review. Sports Med. 2022;53:51-74.
Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873-934.
Eldokla AM, Ali ST. Autonomic function testing in long-COVID syndrome patients with orthostatic intolerance. Auton Neurosci. 2022;241:102997.
Utomi V, Oxborough D, Whyte GP, Somauroo J, Sharma S, Shave R, et al. Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete's heart. Heart. 2013;99(23):1727-33.
Jiang DH, Roy DJ, Gu BJ, Hassett LC, Mccoy RG. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: a state-of-the-art review. JACC Basic Transl Sci. 2021;6(9):796-811.
Long Q, Li J, Hu X, Bai Y, Zheng Y, Gao Z. Follow-ups on persistent symptoms and pulmonary function among post-acute COVID-19 patients: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:702635.
Mayuga KA, Fedorowski A, Ricci F, Gopinathannair R, Dukes JW, Gibbons C, et al. Sinus tachycardia: a multidisciplinary expert focused review. Circ Arrhythm Electrophysiol. 2022;15(9):e007960.
Rivasi G, Groppelli A, Brignole M, Soranna D, Zambon A, Bilo G, et al. Association between hypotension during 24 h ambulatory blood pressure monitoring and reflex syncope: the SynABPM 1 study. Eur Heart J. 2022;43:3765-76.
Puntmann VO, Martin S, Shchendrygina A, Hoffmann J, Ka MM, Giokoglu E, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28:2117-23.
Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993;43(1):132-7.
Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci. 2021;235:102828.
Davis HE, Mccorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-46.
Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, et al. Post-acute COVID-19 syndrome. Eur Respir Rev. 2022;31(163):210185.
Chudzik M, Babicki M, Kapusta J, Kałuzińska-Kołat Ż, Kołat D, Jankowski P, et al. Long-COVID clinical features and risk factors: a retrospective analysis of patients from the STOP-COVID Registry of the PoLoCOV study. Viruses. 2022;14(8):1755.
Larsson AC, Engwall M, Palstam A, Persson HC. Self-assessed aspects of health 3 months after COVID-19 hospitalization - a Swedish cross-sectional study. Int J Environ Res Public Health. 2022;19(13):8020.
Wahlgren C, Divanoglou A, Larsson M, Nilsson E, Östholm Balkhed Å, Niward K, et al. Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms. EClinicalMedicine. 2022;43:101219.
Fernández-De-Las-Peñas C, Guijarro C, Plaza-Canteli S, Hernández-Barrera V, Torres-Macho J. Prevalence of post-COVID-19 cough one year after SARS-CoV-2 infection: a multicenter study. Lung. 2021;199(3):249-53.
Ekbom E, Frithiof R, Emilsson O, Larson I, Lipcsey M, Rubertsson S, et al. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir Med. 2021;182:106394.
Tarraso J, Safont B, Carbonell-Asins JA, Fernandez-Fabrellas E, Sancho-Chust JN, Naval E, et al. Lung function and radiological findings 1 year after COVID-19: a prospective follow-up. Respir Res. 2022;23(1):242.
Lee JH, Yim J-J, Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res. 2022;23(1):233.
Katzenstein TL, Christensen J, Lund TK, Kalhauge A, Rönsholt F, Podlekareva D, et al. Relation of pulmonary diffusing capacity decline to HRCT and VQ SPECT/CT findings at early follow-up after COVID-19: a prospective Cohort Study (the SECURe Study). J Clin Med. 2022;11(19):5687.
Yu JZ, Granberg T, Shams R, Petersson S, Sköld M, Nyrén S, et al. Lung perfusion disturbances in nonhospitalized post-COVID with dyspnea - a magnetic resonance imaging feasibility study. J Intern Med. 2022;292(6):941-56.
Frija-Masson J, Debray M-P, Boussouar S, Khalil A, Bancal C, Motiejunaite J, et al. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: the post Covid M3 study. Respir Med. 2021;184:106435.
Pan F, Yang L, Liang Bo, Ye T, Li L, Li L, et al. Chest CT patterns from diagnosis to 1 year of follow-up in patients with COVID-19. Radiology. 2022;302(3):709-19.
Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73-82.
Mcnarry MA, Berg RMG, Shelley J, Hudson J, Saynor ZL, Duckers J, et al. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J. 2022;60(4):2103101.
Fagevik Olsén M, Lannefors L, Nygren-Bonnier M, Johansson E-L. Long COVID - respiratory symptoms in non-hospitalised subjects - a cross-sectional study. Eur J Physiother. 2022:1-8.
von Gruenewaldt A, Nylander E, Hedman K. Classification and occurrence of an abnormal breathing pattern during cardiopulmonary exercise testing in subjects with persistent symptoms following COVID-19 disease. Physiol Rep. 2022;10(4):e15197.
Frizzelli A, Di Spigno F, Moderato L, Halasz G, Aiello M, Tzani P, et al. An impairment in resting and exertional breathing pattern may occur in long-COVID patients with normal spirometry and unexplained dyspnoea. J Clin Med. 2022;11(24).
Frésard I, Genecand L, Altarelli M, Gex G, Vremaroiu P, Vremaroiu-Coman A, et al. Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in ‘long COVID’ patients with persistent dyspnoea. BMJ Open Respir Res. 2022;9(1):e001126.
McConnell A. Respiratory muscle training: theory and practice. London: Churchill Livingstone; 2013.
Van Voorthuizen EL, Van Helvoort HAC, Peters JB, Van Den Heuvel MM, Van Den Borst B. Persistent exertional dyspnea and perceived exercise intolerance after mild COVID-19: a critical role for breathing dysregulation? Phys Ther. 2022;102(10):pzac105.
Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, Zhang J, Zhao C. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;92(10):1902-14.
Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. Persistent symptoms after Covid-19: qualitative study of 114 “long Covid” patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144.
Vibholm LK, Nielsen SSF, Pahus MH, Frattari GS, Olesen R, Andersen R, et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64:103230.
Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639-44.
Bussani R, Zentilin L, Correa R, Colliva A, Silvestri F, Zacchigna S, et al. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J Pathol. 2023;259(3):254-63.
Arbour N, CôTé Geneviè, Lachance C, Tardieu M, Cashman NR, Talbot PJ. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol. 1999;73(4):3338-50.
Chan PKS, To Ka-F, Lo AWI, Cheung JoLK, Chu I, Au FWL, et al. Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol. 2004;74(1):1-7.
Murray RS, Brown B, Brain D, Cabirac GF. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol. 1992;31(5):525-33.
Zoodsma M, De Nooijer AH, Grondman I, Gupta MK, Bonifacius A, Koeken VACM, et al. Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19. Front Immunol. 2022;13:1027122.
Queiroz MAF, Neves PFMD, Lima SS, Lopes JC, Torres MKS, Vallinoto IMVC, et al. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol. 2022;12:922422.
Shafiee G, Arastou T, Heshmat R, Jamshidi AR, Larijani B, Arzaghi SM. Post COVID-19 neuropsychiatric complications and therapeutic role for TNF-alpha inhibitors: a case series study. J Diab Metab Disord. 2022;21(2):2013-6.
Patterson BK, Guevara-Coto J, Yogendra R, Francisco EB, Long E, Pise A, et al. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. 2021;12:700782.
Tan Z-Y, Lu Y, Whiteis CA, Benson CJ, Chapleau MW, Abboud FM. Acid-sensing ion channels contribute to transduction of extracellular acidosis in rat carotid body glomus cells. Circ Res. 2007;101(10):1009-19.
Youngson C, Nurse C, Yeger H, Cutz E. Oxygen sensing in airway chemoreceptors. Nature. 1993;365(6442):153-5.
Villadiego J, Ramírez-Lorca R, Cala F, Labandeira-García JL, Esteban M, Toledo-Aral JJ, et al. Is carotid body infection responsible for silent hypoxemia in COVID-19 patients? Function (Oxf). 2021;2(1):zqaa032.
Doyle ME, Appleton A, Liu Q-R, Yao Q, Mazucanti CH, Egan JM. Human type II taste cells express angiotensin-converting enzyme 2 and are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Am J Pathol. 2021;191(9):1511-9.
Nikesjö F, Sayyab S, Karlsson L, Apostolou E, Rosén A, Hedman K, et al. Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells. Clin Epigenetics. 2022;14(1):172.
Fedorowski A, Li H, Yu X, Koelsch KA, Harris VM, Liles C, et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017;19(7):1211-9.
Hall J, Bourne KM, Vernino S, Hamrefors V, Kharraziha I, Nilsson J, et al. Detection of G protein-coupled receptor autoantibodies in postural orthostatic tachycardia syndrome using standard methodology. Circulation. 2022;146(8):613-22.
Kharraziha I, Axelsson J, Ricci F, Di Martino G, Persson M, Sutton R, et al. Serum activity against g protein-coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome. J Am Heart Assoc. 2020;9(15):e015989.
Briquez PS, Rouhani SJ, Yu J, Pyzer AR, Trujillo J, Dugan HL, et al. Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Sci Adv. 2022;8(40):eabn3777.
Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194-202.
Utrero-Rico A, Ruiz-Ruigómez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, González-Cuadrado C, et al. A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomedicines. 2021;9(11):1540.
Isaka Y, Hirasawa Y, Terada J, Shionoya Yu, Takeshita Y, Kinouchi T, et al. Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia. Pulm Pharmacol Ther. 2022;72:102108.
Cheng W, Li Y, Cui L, Chen Y, Shan S, Xiao D, et al. Efficacy and safety of corticosteroid treatment in patients with COVID-19: a systematic review and meta-analysis. Front Pharmacol. 2020;11:571156.
Ramakrishnan S, Nicolau DV, Langford B, Mahdi M, Jeffers H, Mwasuku C, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021;9(7):763-72.
Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, et al. The impact of COVID-19 on patients with asthma. Eur Respir J. 2021;57(3):2003142.
Carson E, Hemenway AN. A scoping review of pharmacological management of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection in 2021. Am J Ther. 2022;29(3):e305-21.
Thompson JS, Thornton AC, Ainger T, Garvy BA. Long-term high-dose immunoglobulin successfully treats long COVID patients with pulmonary, neurologic, and cardiologic symptoms. Front Immunol. 2022;13:1033651.
Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28(11):2398-405.
Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of Covid-19 vaccination on long Covid: systematic review. BMJ Med. 2023;2(1):e000385.
Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, et al. Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw Open. 2023;6(1):e2251360.
Chen H, Shi H, Liu X, Sun T, Wu J, Liu Z. Effect of pulmonary rehabilitation for patients with post-COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). 2022;9:837420.
Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther Clin Pract. 2020;39:101166.
Fugazzaro S, Contri A, Esseroukh O, Kaleci S, Croci S, Massari M, et al. Rehabilitation interventions for post-acute COVID-19 syndrome: a systematic review. Int J Environ Res Public Health. 2022;19(9):5185.
Jimeno-Almazán A, Franco-López F, Buendía-Romero Á, Martínez-Cava A, Sánchez-Agar JA, Sánchez-Alcaraz Martínez BJ, et al. Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: a randomized controlled trial. Scand J Med Sci Sports. 2022;32(12):1791-1801.
Okan F, Okan S, Duran Yücesoy F. Evaluating the efficiency of breathing exercises via telemedicine in post-Covid-19 patients: randomized controlled study. Clin Nurs Res. 2022;31(5):771-81.
Philip KEJ, Owles H, Mcvey S, Pagnuco T, Bruce K, Brunjes H, et al. An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Lancet Respir Med. 2022;10(9):851-62.
Abodonya AM, Abdelbasset WK, Awad EA, Elalfy IE, Salem HA, Elsayed SH. Inspiratory muscle training for recovered COVID-19 patients after weaning from mechanical ventilation: a pilot control clinical study. Medicine (Baltimore). 2021;100(13):e25339.
Del Corral T, Fabero-Garrido R, Plaza-Manzano G, Fernández-De-Las-Peñas C, Navarro-Santana M, López-De-Uralde-Villanueva I. Home-based respiratory muscle training on quality of life and exercise tolerance in long-term post-COVID-19: Randomized controlled trial. Ann Phys Rehabil Med. 2022;66(1):101709.
Bouteleux B, Henrot P, Ernst R, Grassion L, Raherison-Semjen C, Beaufils F, et al. Respiratory rehabilitation for Covid-19 related persistent dyspnoea: a one-year experience. Respir Med. 2021;189:106648.
Li J', Xia W, Zhan C, Liu S, Yin Z, Wang J, et al. A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): A randomised controlled trial. Thorax. 2022;77(7):697-706.
Dun Y, Liu C, Ripley-Gonzalez JW, Liu P, Zhou N, Gong X, et al. Six-month outcomes and effect of pulmonary rehabilitation among patients hospitalized with COVID-19: a retrospective cohort study. Ann Med. 2021;53(1):2099-109.
Nopp S, Moik F, Klok FA, Gattinger D, Petrovic M, Vonbank K, et al. Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. 2022;101(6):593-601.
Gloeckl R, Leitl D, Jarosch I, Schneeberger T, Nell C, Stenzel N, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021;7(2):00108-2021.
Chaichana U, Man KKC, Chen A, Wong ICK, George J, Wilson P, Wei L. Definition of post-COVID-19 condition among published research studies. JAMA Netw Open. 2023;6(4):e235856.